News
Alnylam Shares Findings On Delivering siRNA Beyond The Liver
Alnylam has outlined their strategy for delivering siRNA to the central nervous system and other organs outside of the liver. The RNA specialist detailed how the coupling of its drug candidates permitted therapeutic suppression of target genes across the...
News
With Keytruda, Merck Sees 80 Plus Eligible Oncology Wins
Merck & Co. was not at all a prominent oncology player before the advent of Keytruda. The New Jersey drugmaker wants to consolidate its supremacy now that it has the world's best-selling cancer medication. Jannie Oosthuizen, Merck's head of global...
News
Lunsumio, Blood Cancer Drug By Roche Gets Global Approval
Roche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a novel bispecific lymphoma medicine with a first-in-class clearance that will compete with strong CAR-T therapies.
Lunsumio, or mosunetuzumab, has acquired...
News
Each Patient In The Clinical Study Sees The Cancer Vanish
It was a small study, with only 18 rectal cancer sufferers taking the same medicine.
However, the outcomes were astounding. Every single patient's cancer vanished, undetected by physical examination, endoscopy, positron emission tomography, PET scans, or MRI scans.
Dr. Luis A. Diaz...
Drug Research
New Drug Mix From ICR And The Royal Marsden Shows Promise
The findings of a phase 1 trial examining a medication mixture targeting multiple mutant variants of cancer's 'death star' protein have been released by the Institute of Cancer Research (ICR) in London and The Royal Marsden NHS Foundation Trust.
In...
News
Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners
Thermo Fisher Scientific, the world leader in serving science, announces the winners of the 2022 Thermo Scientific Tandem Mass Tag (TMT) Research Award. Now in its eighth year, the research competition selects scientists from a pool of international applicants...
News
Thermo Fisher Scientific Collaborates with TransMIT GmbH on a High-Performance Orbitrap Mass Spectrometry Imaging Platform
Thermo Fisher Scientific Inc., the world leader in serving science, and TransMIT GmbH Center for Mass Spectrometric Developments have announced a co-marketing agreement to promote the use of a mass spectrometry imaging (MSI) platform for spatial multi-omics applications in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read